Akèy › Kansè (tout kalite) › Utah › West Valley City
Etid klinik pou Kansè (tout kalite) nan West Valley City, UT
11 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote West Valley City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Ap rekriteFaz 2
- START Mountain Region ( Site 1106), West Valley City
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Ap rekriteFaz 1
- START Mountain Region, West Valley City
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Ap rekriteFaz 1/2
- START Mountain Region, West Valley City
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
Ap rekriteFaz 1/2
- Site 02, West Valley City
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
Ap rekriteFaz 1
- START Mountain Region, West Valley City
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- START Mountain Region, LLC., West Valley City
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- START Mountain Region, West Valley City
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
Ap rekriteFaz 1
- GSK Investigational Site, West Valley City
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
Ap rekriteFaz 1
- GSK Investigational Site, West Valley City
Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
Ap rekriteFaz 1
- START Mountain Region, West Valley City
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
Ap rekriteFaz 1
- START Mountain Region, West Valley City
Etid Kansè (tout kalite) nan lòt vil
- Houston, TX121 etid
- New York City, NY109 etid
- Boston, MA85 etid
- Los Angeles, CA74 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Washington, DC58 etid
- Durham, NC58 etid
- Chicago, IL51 etid
- Atlanta, GA49 etid
- Seattle, WA49 etid
- Arlington, VA48 etid
Lòt etid nan West Valley City
- Kansè Poumon ki pa ti selil25 etid
- Kansè kolorektal17 etid
- Kansè nan tete13 etid
- Kansè tete negatif triple13 etid
- Kansè Metastatik13 etid
- Kansè pankreyas12 etid
- Kansè ovè11 etid
- Karsinòm selil skuamèz tèt ak kou11 etid
- Kansè Endomèt10 etid
- Kansè lestomak8 etid
- Kasinom Selil Skwamoz Ezofajyen7 etid
- Kansè poumon selil ti7 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.